Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sanofi ADR (SNY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sanofi ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
49.71 +0.53    +1.08%
05/08 - Closed. Currency in USD ( Disclaimer )
After Hours
50.01
+0.30
+0.60%
0:25:19 - Real-time Data
  • Volume: 859,887
  • Bid/Ask: 49.16 / 50.01
  • Day's Range: 49.17 - 49.78
Type:  Equity
Market:  United States
Sanofi ADR 49.71 +0.53 +1.08%
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
30/06
2022
31/03
2021
31/12
2021
30/09
Total Revenue 10742 10053 21244 10829
Revenue 10116 10053 21244 10829
Other Revenue, Total 626 - - -
Cost of Revenue, Total 3250 2880 6714 3238
Gross Profit 7492 7173 14530 7591
Total Operating Expenses 8590 7656 16731 7787
Selling/General/Admin. Expenses, Total 2574 2379 5025 2267
Research & Development 1658 1489 3029 1443
Depreciation / Amortization - 449 805 385
Interest Expense (Income) - Net Operating -101 - - -
Unusual Expense (Income) - 198 512 170
Other Operating Expenses, Total 1209 261 646 284
Operating Income 2152 2397 4513 3042
Interest Income (Expense), Net Non-Operating - -78 -153 -85
Gain (Loss) on Sale of Assets - - - -
Other, Net 769 - -14 -
Net Income Before Taxes 1383 2319 4346 2957
Provision for Income Taxes 163 332 876 609
Net Income After Taxes 1220 1987 3470 2348
Minority Interest 353 -8 -36 -26
Equity In Affiliates - 30 13 -5
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1175 2009 3447 2317
Total Extraordinary Items - - - -
Net Income 1175 2009 3447 2317
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1175 2009 3447 2317
Dilution Adjustment - - - -
Diluted Net Income 1175 2009 3447 2317
Diluted Weighted Average Shares 1250.8 1249.2 1260.2 1254.5
Diluted EPS Excluding Extraordinary Items 0.939 1.61 2.74 1.85
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 1.01 1.74 3.06 1.95
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email